Immune cell infiltration and inflammatory landscape in primary brain tumours
Amalia Luce(University of Campania "Luigi Vanvitelli"), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Gabriella Misso(University of Campania "Luigi Vanvitelli"), Roberto Di Monaco, O Sepe(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giosuè Scognamiglio(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Silvia Zappavigna(University of Campania "Luigi Vanvitelli"), Vincenzo Gigantino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gerardo Ferrara(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gianfranco De Dominicis, Renato Franco(Istituto di Chimica Biomolecolare), Vittorio Gentile(University of Campania "Luigi Vanvitelli"), Domenico Iervolino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Severo Campione(Federico II University Hospital), Marianna Abate(University of Campania "Luigi Vanvitelli"), Madhura S. Tathode(University of Campania "Luigi Vanvitelli"), Marco Montella(University of Campania "Luigi Vanvitelli"), Annabella Di Mauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 13
Related Papers
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
|PLoS ONE|2014|115
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
|Cell Death and Disease|2013|57
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
|British Journal of Cancer|2010|49